The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase-dependent mechanism.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Jean-Luc Coll Blaise Robin Marie Wislez Benoit Busser Jacques Cadranel |
| Publication date | December 13, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |